RECURSION PHARMACEUTICALS INCRECURSION PHARMACEUTICALS INCRECURSION PHARMACEUTICALS INC

RECURSION PHARMACEUTICALS INC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪73.71 B‬MXN
−30.11MXN
‪−5.57 B‬MXN
‪757.11 M‬MXN
‪296.92 M‬
Beta (1Y)
3.78

About Recursion Pharmaceuticals, Inc.


CEO
Chistopher C. Gibson
Headquarters
Salt Lake City
Founded
2013
FIGI
BBG01S8283L6
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 5, 2013 and is headquartered in Salt Lake City, UT.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of RXRX is 209.00 MXN — it has decreased by −4.57% in the past 24 hours. Watch RECURSION PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange RECURSION PHARMACEUTICALS INC stocks are traded under the ticker RXRX.
RXRX stock has risen by 4.50% compared to the previous week, the month change is a 4.50% rise, over the last year RECURSION PHARMACEUTICALS INC has showed a 4.50% increase.
We've gathered analysts' opinions on RECURSION PHARMACEUTICALS INC future price: according to them, RXRX price has a max estimate of 227.09 MXN and a min estimate of 123.87 MXN. Watch RXRX chart and read a more detailed RECURSION PHARMACEUTICALS INC stock forecast: see what analysts think of RECURSION PHARMACEUTICALS INC and suggest that you do with its stocks.
RXRX reached its all-time high on Feb 14, 2025 with the price of 200.00 MXN, and its all-time low was 200.00 MXN and was reached on Feb 14, 2025. View more price dynamics on RXRX chart.
See other stocks reaching their highest and lowest prices.
RXRX stock is 5.04% volatile and has beta coefficient of 3.78. Track RECURSION PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is RECURSION PHARMACEUTICALS INC there?
Today RECURSION PHARMACEUTICALS INC has the market capitalization of ‪73.71 B‬, it has decreased by −3.40% over the last week.
Yes, you can track RECURSION PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
RECURSION PHARMACEUTICALS INC is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
RXRX earnings for the last quarter are −6.70 MXN per share, whereas the estimation was −6.56 MXN resulting in a −2.15% surprise. The estimated earnings for the next quarter are −8.58 MXN per share. See more details about RECURSION PHARMACEUTICALS INC earnings.
RECURSION PHARMACEUTICALS INC revenue for the last quarter amounts to ‪513.91 M‬ MXN, despite the estimated figure of ‪368.80 M‬ MXN. In the next quarter, revenue is expected to reach ‪319.29 M‬ MXN.
RXRX net income for the last quarter is ‪−1.89 B‬ MXN, while the quarter before that showed ‪−1.79 B‬ MXN of net income which accounts for −5.55% change. Track more RECURSION PHARMACEUTICALS INC financial stats to get the full picture.
No, RXRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RECURSION PHARMACEUTICALS INC EBITDA is ‪−7.20 B‬ MXN, and current EBITDA margin is −712.50%. See more stats in RECURSION PHARMACEUTICALS INC financial statements.
Like other stocks, RXRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RECURSION PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.